Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Cell Reactant: | HIV-1 Protease Mutant (V82F/I84V) | ||
| Syringe Reactant: | BDBM517 | ||
| Meas. Tech.: | Isothermal Titration Calorimetry | ||
| Entry Date: | 04/20/04 | ||
| ΔG°: | -38.5± (kJ/mole) | ||
| pH: | 5±n/a | ||
| Log10Kb: | n/a | ||
| Temperature: | 298.15±n/a (K) | ||
| ΔH° : | 24.7±0.836 (kJ/mole) | ||
| ΔHobs : | 24.4± (kJ/mole) | ||
| Ionic Strength: | n/a | ||
| not known | |||
| Protons Released: | 0.5 | ||
| ΔCp : | -2.4244±0.2508 (kJ/mole) | ||
| Stoich. Param.: | n/a | ||
| ΔS° : | 0.2118± (kJ/mole-K) | ||
| Comments: | n/a | ||
| Citation |  Todd, MJ; Luque, I; Velázquez-Campoy, A; Freire, E Thermodynamic basis of resistance to HIV-1 protease inhibition: calorimetric analysis of the V82F/I84V active site resistant mutant. Biochemistry39:11876-83 (2000) [PubMed] Article | ||
| More Info.: | Get all data from this article , ITC RUN data , Solution Info , Data Fit Method , Instrument Info | ||
| HIV-1 Protease Mutant (V82F/I84V) | |||
| Source: | mutations at position 82 and 84 were introduced using an in vitro site-directed mutagenesis kit, mutant protease was expressed in BL21/DE3 | ||
| Purity: | 99% | ||
| Prep. Method: | HIV-1 protease was purified and refolded from E. coli inclusion bodies. | ||
| Name: | HIV-1 Protease Mutant (V82F/I84V) | ||
| Synonyms: | n/a | ||
| Type: | Protein Complex | ||
| Mol. Mass.: | n/a | ||
| Description: | n/a | ||
| Components: | This complex has 2 components. | ||
| Component 1 | |||
| Name: | HIV-1 Protease Mutant (V82F/I84V) chain A | ||
| Synonyms: | HIV-1 Protease Mutant (V82F/I84V) chain B | ||
| Type: | Enzyme Subunit | ||
| Mol. Mass.: | 10816.23 | ||
| Organism: | Human immunodeficiency virus type 1 | ||
| Description: | Using plasmid-encoded mutant protease (Q7K/L33I/L63I designed to remove three hypersensitive autolytic sites) for the stability of protease. | ||
| Residue: | 99 | ||
| Sequence: |
| ||
| Component 2 | |||
| Name: | HIV-1 Protease Mutant (V82F/I84V) chain A | ||
| Synonyms: | HIV-1 Protease Mutant (V82F/I84V) chain B | ||
| Type: | Enzyme Subunit | ||
| Mol. Mass.: | 10816.23 | ||
| Organism: | Human immunodeficiency virus type 1 | ||
| Description: | Using plasmid-encoded mutant protease (Q7K/L33I/L63I designed to remove three hypersensitive autolytic sites) for the stability of protease. | ||
| Residue: | 99 | ||
| Sequence: |
| ||
| BDBM517 | |||
| Source: | Purified from commercial capsules | ||
| Purity: | n/a | ||
| Prep. Method: | Further purified by HPLC using a semipreparative C-18 reversed-phase column developed with 0-100% acetonitrile in 0.05% TFA | ||
| Name | BDBM517 | ||
| Synonyms: | (2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide | CHEMBL115 | Crixivan | INDINAVIR SULFATE | Indinavir | Indinavir, 19 | L-735, 524 | MK639 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C36H47N5O4 | ||
| Mol. Mass. | 613.7895 | ||
| SMILES | CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H]1[C@H](O)Cc2ccccc12 |@:19,@@:9| | ||
| Structure | 
| ||
|
Home |
| |
Search |
| |
Deposit |
| |
SiteMap |
| |
About us |
| |
Email us |
| |
Info |
|
©2000 BindingDB. All rights reserved. |
|||||||||||||